{"database": "lobbying", "table": "lobbying_activities", "rows": [[3008233, "908e37a5-d53b-4e94-b77b-9e464def28d2", "Q2", "STUMPTOWN STRATEGIES", 401106433, "PRIME THERAPEUTICS", 2023, "second_quarter", "PHA", "Introduction to Prime to new Members of the 118th Congress Monitoring PBM Legislation (bill numbers not yet finalized)", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2023-07-17T18:14:21-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3008233"], "units": {}, "query_ms": 19.113408983685076, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}